Dr. Thomas Stinchcombe on Targeted Therapies in Squamous Cell Lung Cancer
Thomas Stinchcombe, MD, discusses the complicated nature of squamous cell lung cancer. Stinchcombe says that there has been a recent boom in targeted therapies for non-squamous cell lung cancer, though not as much research in squamous cell lung cancer due to its multitude of mutations.
Thomas Stinchcombe, MD, assistant professor in the Division of Hematology and Oncology, codirector of the multidisciplinary thoracic oncology program, University of North Carolina Lineberger Cancer Center, discusses the complicated nature of squamous cell lung cancer. Stinchcombe says that there has been a recent boom in targeted therapies for non-squamous cell lung cancer, though not as much research in squamous cell lung cancer due to its multitude of mutations.
